Byrne Asset Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25
| Closed | -$727 | – | 557 |
|
|
2024
Q1 | $727 | Hold |
25
| – | – | ﹤0.01% | 518 |
|
|
2023
Q4 | $734 | Sell |
25
-650
| -96% | -$19.1K | ﹤0.01% | 525 |
|
|
2023
Q3 | $15K | Buy |
+675
| New | +$15K | 0.01% | 301 |
|
|
2023
Q2 | – | Sell |
-675
| Closed | -$33K | – | 296 |
|
|
2023
Q1 | $33K | Buy |
675
+150
| +29% | +$7.33K | 0.02% | 258 |
|
|
2022
Q4 | $20K | Hold |
525
| – | – | 0.01% | 322 |
|
|
2022
Q3 | $26K | Hold |
525
| – | – | 0.02% | 264 |
|
|
2022
Q2 | $21K | Hold |
525
| – | – | 0.02% | 273 |
|
|
2022
Q1 | $20K | Hold |
525
| – | – | 0.01% | 309 |
|
|
2021
Q4 | $21K | Buy |
+525
| New | +$21K | 0.01% | 287 |
|